Effect of simvastatin on neuroinflammation in microglial cells via mitogen-activated protein kinase and nuclear factor κb pathways

Hongying Ma, Dingan Li, Thamaraiselvan Rengarajan, Kalaivani Manokaran*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Background: Activated microglial cells are found in different sorts of the neurodegenerative process including Parkinson and Alzheimer. Suppressing the activated microglial cells developed as a novel procedure for the treatment of neuroinflammation-based neurodegeneration. Materials and Methods: We have investigated the effects of simvastatin on memory impairment and inflammatory cytokines expression induced by transient cerebral ischemia in cultured microglial cells. Results: The lipopolysaccharide (LPS)-activated microglial cells treated with simvastatin 3 μmol has decreased the inflammation which was indicated by the reduced levels of the nitric oxide (NO), tumor necrosis factor-α, interleukin-1 β, cyclooxygenase-2, and inducible NO synthase. Simvastatin also delayed the activation of atomic component nuclear factor-κB, p38 mitogen-activated protein kinase, and the reactive oxygen species in LPS-activated microglial cells. Moreover, simvastatin has provoked the outflow of heme oxygenase-1 in BV-2 microglial cells. Conclusions: The present study showed that the simvastatin antagonizes neuroinflammation and can be a potential restorative operator for treating neuroinflammatory ailments.

Original languageEnglish
Pages (from-to)S237-S244
JournalPharmacognosy Magazine
Volume14
Issue number55
DOIs
Publication statusPublished - 01-04-2018

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Effect of simvastatin on neuroinflammation in microglial cells via mitogen-activated protein kinase and nuclear factor κb pathways'. Together they form a unique fingerprint.

Cite this